Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FWD1802 in ER+/HER2- advanced breast cancer
NCT07002177Phase 2Recruiting
- Start
- Jun 2025
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fwd1802 in breast cancer. Started Jun 2025; status: recruiting.
02
Drugs
fwd1802
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07002177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07002177.